首页> 外国专利> DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF HLA-E MONOSPECIFIC MONOCLONAL IgG ANTIBODIES DIRECTED AGAINST TUMOR CELL SURFACE AND SOLUBLE HLA-E

DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF HLA-E MONOSPECIFIC MONOCLONAL IgG ANTIBODIES DIRECTED AGAINST TUMOR CELL SURFACE AND SOLUBLE HLA-E

机译:针对肿瘤细胞表面和可溶性HLA-E的HLA-E单特异性IgG单克隆抗体的诊断和治疗潜力

摘要

Provided herein are compositions comprising purified antibodies and fragments thereof that are specifically immunoreactive to only human leukocyte antigen E (HLA-E) but not to other HLA Ia and HLA-Ib alleles. Also provided are methods of their making and diagnostic and therapeutic applications. The monospecific HLA-E antibodies are highly specific and can be used for diagnosing or localizing the presence of HLA-E on normal or diseased cells or tissues. The monospecific HLA-E antibodies can also be used for cancer therapies, likely through regulation of the CD94/NKG2a on Cytotoxic and/or Natural Killer T cells.
机译:本文提供了包含纯化的抗体及其片段的组合物,所述纯化的抗体及其片段仅对人白细胞抗原E(HLA-E)具有特异性免疫反应,而对其他HLA Ia和HLA-Ib等位基因没有特异性。还提供了它们的制造方法以及诊断和治疗应用。单特异性HLA-E抗体具有高度特异性,可用于诊断或定位正常或患病细胞或组织上HLA-E的存在。单特异性HLA-E抗体也可以用于癌症治疗,可能是通过调节CD94 / NKG2a对细胞毒性和/或自然杀伤性T细胞的作用。

著录项

  • 公开/公告号EP2870179A2

    专利类型

  • 公开/公告日2015-05-13

    原文格式PDF

  • 申请/专利权人 THE TERASAKI FAMILY FOUNDATION;

    申请/专利号EP20130813710

  • 发明设计人 RAVINDRANATH MEPUR H.;TERASAKI PAUL I.;

    申请日2013-07-01

  • 分类号C07K16/28;G01N33/577;A61K39;A61K39/395;A61P35;A61P7;A61P29;A61P37;

  • 国家 EP

  • 入库时间 2022-08-21 15:02:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号